Science and Research

Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease

BACKGROUND: Patients with end stage renal disease (ESRD) undergoing hemodialysis are at increased risk for infection and impaired vaccination responses. We analyzed overlap and influencing factors of vaccination responses against severe acute respiratory syndrome corona virus disease 2 (SARS-CoV-2) and Hepatitis B virus (HBV). METHODS: SARS-CoV-2 and HBV vaccination response was assessed in a cohort of German ESRD hemodialysis patients. Anti-HBs- and SARS-CoV-2 anti-S-IgG were analyzed by ELISA. Demographic and clinical data were extracted from clinical files. RESULTS: Sixty-four patients with complete information on HBV and SARS-CoV-2 vaccination responses were included. More than one-third (35.4%) of non-responders upon HBV vaccination were identified. Unresponsiveness after HBV and poor response after SARS-CoV-2 vaccination showed strong overlap, and overall, 70.3% of patients were classified into concordant HBV/SARS vaccination response groups. HBV vaccination non-responsiveness, but not poor SARS-CoV-2 post-vaccination immunity was associated with obesity, while poor SARS-CoV-2 vaccination responses were associated increased age. CONCLUSION: Our findings confirm previous reports on impaired vaccination response in hemodialysis patients and show that post-vaccination humoral responses against SARS-CoV-2 and HBV display strong overlap in this vulnerable patient group. These results may help to adapt vaccination strategies in this highly vulnerable population. TRIAL REGISTRATION: German Clinical Trial Registry, DRKS00021152.

  • Lürken, K.
  • Meinecke, A.
  • Manthey, L. A.
  • Cossmann, A.
  • Stankov, M. V.
  • Klawonn, F.
  • Zychlinsky Scharff, A.
  • Steffens, S.
  • Dopfer-Jablonka, A.
  • Müller, F.
  • Behrens, G. M. N.
  • Happle, C.

Keywords

  • Humans
  • *Renal Dialysis
  • Male
  • Female
  • *Kidney Failure, Chronic/therapy/immunology
  • Middle Aged
  • *COVID-19/immunology/prevention & control
  • *COVID-19 Vaccines/immunology/administration & dosage
  • *Hepatitis B Vaccines/immunology/administration & dosage
  • Aged
  • *Hepatitis B/immunology/prevention & control
  • *SARS-CoV-2/immunology
  • Vaccination
  • Germany/epidemiology
  • Adult
  • Hbv
  • Hemodialysis
  • SARS-CoV-2
  • Vaccination response
Publication details
DOI: 10.1186/s40001-025-02274-3
Journal: Eur J Med Res
Pages: 34 
Number: 1
Work Type: Original
Location: BREATH
Disease Area: PALI
Partner / Member: MHH
Access-Number: 39819737

DZL Engagements

chevron-down